Skip to main content
. 2020 Aug 20;10(4):353–365. doi: 10.1002/cpdd.855

Figure 3.

Figure 3

Time course (log‐linear scale) of mean plasma concentrations of apararenone and eplerenone after single oral administration of apararenone and eplerenone (A) and time course of mean urinary sodium/potassium (Na+/K+) ratio (B) in study 3.